136 related articles for article (PubMed ID: 34149037)
1. Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer.
Hirko KA; Regan MM; Remolano MC; Schlossman J; Harrison B; Yeh E; Jacene H; Nakhlis F; Block C; Rosenbluth JM; Garrido-Castro AC; Overmoyer BA
Am J Clin Oncol; 2021 Sep; 44(9):449-455. PubMed ID: 34149037
[TBL] [Abstract][Full Text] [Related]
2. Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiation.
Abramowitz MC; Li T; Morrow M; Sigurdson ER; Anderson P; Nicolaou N; Freedman G
Am J Clin Oncol; 2009 Feb; 32(1):30-3. PubMed ID: 19194121
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation.
Lacerda L; Reddy JP; Liu D; Larson R; Li L; Masuda H; Brewer T; Debeb BG; Xu W; Hortobágyi GN; Buchholz TA; Ueno NT; Woodward WA
Stem Cells Transl Med; 2014 Jul; 3(7):849-56. PubMed ID: 24833589
[TBL] [Abstract][Full Text] [Related]
4. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
Fouad TM; Kogawa T; Liu DD; Shen Y; Masuda H; El-Zein R; Woodward WA; Chavez-MacGregor M; Alvarez RH; Arun B; Lucci A; Krishnamurthy S; Babiera G; Buchholz TA; Valero V; Ueno NT
Breast Cancer Res Treat; 2015 Jul; 152(2):407-16. PubMed ID: 26017070
[TBL] [Abstract][Full Text] [Related]
5. EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer.
Debeb BG; Gong Y; Atkinson RL; Sneige N; Huo L; Gonzalez-Angulo AM; Hung MC; Valero V; Ueno NT; Woodward WA
J Exp Clin Cancer Res; 2014 Jul; 33(1):58. PubMed ID: 25051981
[TBL] [Abstract][Full Text] [Related]
6. Identifying factors that impact survival among women with inflammatory breast cancer.
Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
Ann Oncol; 2012 Apr; 23(4):870-5. PubMed ID: 21765048
[TBL] [Abstract][Full Text] [Related]
7. Development of CNS metastases and survival in patients with inflammatory breast cancer.
Uemura MI; French JT; Hess KR; Liu D; Raghav K; Hortobagyi GN; Arun BK; Valero V; Ueno NT; Alvarez RH; Woodward WA; Debeb BG; Moulder SL; Lim B; Tripathy D; Ibrahim NK
Cancer; 2018 Jun; 124(11):2299-2305. PubMed ID: 29579338
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Breast Cancer at the Extremes of Age.
Adesoye T; Babayemi O; Postlewait LM; DeSnyder SM; Sun SX; Woodward WA; Ueno NT; Hunt KK; Lucci A; Teshome M
Ann Surg Oncol; 2021 Oct; 28(10):5626-5634. PubMed ID: 34292426
[TBL] [Abstract][Full Text] [Related]
9. Initial response to chemotherapy, not delay in diagnosis, predicts overall survival in inflammatory breast cancer cases.
Hoffman HJ; Khan A; Ajmera KM; Zolfaghari L; Schenfeld JR; Levine PH
Am J Clin Oncol; 2014 Aug; 37(4):315-21. PubMed ID: 23241503
[TBL] [Abstract][Full Text] [Related]
10. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of dermal lymphatic invasion with or without clinical signs of inflammatory breast cancer.
Gruber G; Ciriolo M; Altermatt HJ; Aebi S; Berclaz G; Greiner RH
Int J Cancer; 2004 Mar; 109(1):144-8. PubMed ID: 14735481
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction.
Raghav K; French JT; Ueno NT; Lei X; Krishnamurthy S; Reuben JM; Valero V; Ibrahim NK
PLoS One; 2016; 11(1):e0145534. PubMed ID: 26752563
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for locoregional failure in patients with inflammatory breast cancer treated with trimodality therapy.
Saigal K; Hurley J; Takita C; Reis IM; Zhao W; Rodgers SE; Wright JL
Clin Breast Cancer; 2013 Oct; 13(5):335-43. PubMed ID: 23850216
[TBL] [Abstract][Full Text] [Related]
14. Incidence of and survival following brain metastases among women with inflammatory breast cancer.
Dawood S; Ueno NT; Valero V; Andreopoulou E; Hsu L; Lara J; Woodward W; Buchholz TA; Hortobagyi GN; Cristofanilli M
Ann Oncol; 2010 Dec; 21(12):2348-2355. PubMed ID: 20439340
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcome of bone-only metastasis in inflammatory and noninflammatory breast cancers.
Kai M; Kogawa T; Liu DD; Fouad TM; Kai K; Niikura N; Hsu L; Willey JS; Theriault RL; Valero V; Ueno NT
Clin Breast Cancer; 2015 Feb; 15(1):37-42. PubMed ID: 25258308
[TBL] [Abstract][Full Text] [Related]
16. Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer.
van Uden DJP; van Maaren MC; Bult P; Strobbe LJA; van der Hoeven JJM; Blanken-Peeters CFJM; Siesling S; de Wilt JHW
Breast Cancer Res Treat; 2019 Jul; 176(1):217-226. PubMed ID: 30972613
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.
Nakhlis F; Regan MM; Warren LE; Bellon JR; Hirshfield-Bartek J; Duggan MM; Dominici LS; Golshan M; Jacene HA; Yeh ED; Mullaney EE; Overmoyer B
Ann Surg Oncol; 2017 Sep; 24(9):2563-2569. PubMed ID: 28560598
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program.
Li J; Xia Y; Wu Q; Zhu S; Chen C; Yang W; Wei W; Sun S
Oncotarget; 2017 Jul; 8(30):49370-49379. PubMed ID: 28472761
[TBL] [Abstract][Full Text] [Related]
19. Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
Hieken TJ; Murphy BL; Boughey JC; Degnim AC; Glazebrook KN; Hoskin TL
Clin Breast Cancer; 2018 Aug; 18(4):e501-e506. PubMed ID: 29089281
[TBL] [Abstract][Full Text] [Related]
20. Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study.
Diessner J; Van Ewijk R; Weiss CR; Janni W; Wischnewsky MB; Kreienberg R; Hancke K; Blettner M; Wöckel A; Schwentner L
Arch Gynecol Obstet; 2015 Sep; 292(3):655-64. PubMed ID: 25814296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
